141 related articles for article (PubMed ID: 23315400)
41. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
42. External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle.
Tawadros C; Burnett K; Derbyshire LF; Tawadros T; Clarke NW; Betts CD
BJU Int; 2015 Sep; 116(3):423-31. PubMed ID: 25600712
[TBL] [Abstract][Full Text] [Related]
43. Acute alcohol intoxication in women: relationship to dose and menstrual cycle phase.
Sutker PB; Goist KC; King AR
Alcohol Clin Exp Res; 1987 Feb; 11(1):74-9. PubMed ID: 3105344
[TBL] [Abstract][Full Text] [Related]
44. Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives.
Heintz B; Schmauder C; Witte K; Breuer I; Baltzer K; Sieberth HG; Lemmer B
J Hypertens; 1996 Mar; 14(3):333-9. PubMed ID: 8723987
[TBL] [Abstract][Full Text] [Related]
45. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
46. The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals.
van Heeswijk RP; Veldkamp AI; Hoetelmans RM; Mulder JW; Schreij G; Hsu A; Lange JM; Beijnen JH; Meenhorst PL
AIDS; 1999 Oct; 13(14):F95-9. PubMed ID: 10513637
[TBL] [Abstract][Full Text] [Related]
47. LH and FSH responses to luteinizing releasing hormone in normal fertile women.
Wollesen F; Swerdloff RS; Odell WD
Metabolism; 1976 Nov; 25(11):1275-85. PubMed ID: 790081
[TBL] [Abstract][Full Text] [Related]
48. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.
Kimball A; Dichtel LE; Nyer MB; Mischoulon D; Fisher LB; Cusin C; Dording CM; Trinh NH; Yeung A; Haines MS; Sung JC; Pinna G; Rasmusson AM; Carpenter LL; Fava M; Klibanski A; Miller KK
Psychoneuroendocrinology; 2020 Feb; 112():104512. PubMed ID: 31780185
[TBL] [Abstract][Full Text] [Related]
49. [Perception of ischemic and pressing pain in young women during menstrual cycle. Association with humor and cortisol levels].
Viana Ede S; da Silva SB; de Sousa MB
Acta Cir Bras; 2005; 20 Suppl 1():220-6. PubMed ID: 17768810
[TBL] [Abstract][Full Text] [Related]
50. Menstrual bleeding, cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled analysis of three cohorts.
Najmabadi S; Schliep KC; Simonsen SE; Porucznik CA; Egger MJ; Stanford JB
Paediatr Perinat Epidemiol; 2020 May; 34(3):318-327. PubMed ID: 32104920
[TBL] [Abstract][Full Text] [Related]
51. The influence of the menstrual cycle on triazolam and indocyanine green pharmacokinetics.
Kamimori GH; Sirisuth N; Greenblatt DJ; Eddington ND
J Clin Pharmacol; 2000 Jul; 40(7):739-44. PubMed ID: 10883415
[TBL] [Abstract][Full Text] [Related]
52. Influence of menstrual cycle and gender on alprazolam pharmacokinetics.
Kirkwood C; Moore A; Hayes P; DeVane CL; Pelonero A
Clin Pharmacol Ther; 1991 Oct; 50(4):404-9. PubMed ID: 1914376
[TBL] [Abstract][Full Text] [Related]
53. Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.
Kappelhoff BS; Huitema AD; Sankatsing SU; Meenhorst PL; Van Gorp EC; Mulder JW; Prins JM; Beijnen JH
Br J Clin Pharmacol; 2005 Sep; 60(3):276-86. PubMed ID: 16120066
[TBL] [Abstract][Full Text] [Related]
54. Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals.
Acosta EP; Wu H; Hammer SM; Yu S; Kuritzkes DR; Walawander A; Eron JJ; Fichtenbaum CJ; Pettinelli C; Neath D; Ferguson E; Saah AJ; Gerber JG;
J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1358-66. PubMed ID: 15483465
[TBL] [Abstract][Full Text] [Related]
55. Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV.
Hessol NA; Holman S; Minkoff H; Cohen MH; Golub ET; Kassaye S; Karim R; Sosanya O; Shaheen C; Merhi Z
AIDS Care; 2016; 28(1):11-21. PubMed ID: 26274806
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients.
Boyd M; Mootsikapun P; Burger D; Chuenyam T; Ubolyam S; Mahanontharit A; Sangkote J; Bunyaprawit P; Horsakulchai M; Lange J; Cooper D; Phanuphak P; Ruxrungtham K
Antivir Ther; 2005; 10(2):301-7. PubMed ID: 15865224
[TBL] [Abstract][Full Text] [Related]
57. Resting metabolic rate and thermic effect of a meal in the follicular and luteal phases of the menstrual cycle in well-nourished Indian women.
Piers LS; Diggavi SN; Rijskamp J; van Raaij JM; Shetty PS; Hautvast JG
Am J Clin Nutr; 1995 Feb; 61(2):296-302. PubMed ID: 7840066
[TBL] [Abstract][Full Text] [Related]
58. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.
Hamzeh FM; Benson C; Gerber J; Currier J; McCrea J; Deutsch P; Ruan P; Wu H; Lee J; Flexner C;
Clin Pharmacol Ther; 2003 Mar; 73(3):159-69. PubMed ID: 12621381
[TBL] [Abstract][Full Text] [Related]
59. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
60. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin.
Bouman A; Moes H; Heineman MJ; de Leij LF; Faas MM
Fertil Steril; 2001 Sep; 76(3):555-9. PubMed ID: 11532481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
